Bluejay Diagnostics Enters Material Definitive Agreement

Ticker: BJDX · Form: 8-K · Filed: Jul 28, 2025 · CIK: 1704287

Sentiment: neutral

Topics: material-definitive-agreement, filing

TL;DR

Bluejay Diagnostics signed a big deal on 7/23. Details to follow.

AI Summary

On July 23, 2025, Bluejay Diagnostics, Inc. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in Acton, MA, filed this 8-K report on July 28, 2025, detailing the agreement.

Why It Matters

This filing indicates a significant new contract or partnership for Bluejay Diagnostics, which could impact its future operations and financial performance.

Risk Assessment

Risk Level: medium — Entering into a material definitive agreement is a significant event that could carry substantial implications, both positive and negative, for the company.

Key Numbers

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Bluejay Diagnostics?

The filing states that Bluejay Diagnostics, Inc. entered into a material definitive agreement on July 23, 2025, but the specific details of this agreement are not provided in the provided text.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted to the SEC on July 28, 2025.

Where are Bluejay Diagnostics' principal executive offices located?

Bluejay Diagnostics, Inc.'s principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.

What is the company's fiscal year end?

The company's fiscal year ends on December 31.

What is the SIC code for Bluejay Diagnostics?

The Standard Industrial Classification (SIC) code for Bluejay Diagnostics is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 28, 2025 regarding Bluejay Diagnostics, Inc. (BJDX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing